small molecule

DYLOJECT

DICLOFENAC SODIUM

Loss of exclusivityMarch 2027latest FDA-listed patent expiry
CompanyJAVELIN PHARMACEUTICALS INC A WHOLLY OWNED SUDSIDIARY OF HOSPIRA INC

Drug detail

Brand nameDYLOJECT
Active ingredientDICLOFENAC SODIUM
Strength37.5MG/ML (37.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalDecember 2014
Marketing statusDISCN

Listed patents

PatentExpiresType
8946292March 2027use U-1659

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.